Dec. 20, 2017

Evaluation of the Evolved Expendable Launch Vehicle Program Quality Management System DODIG-2018-045

We determined whether the DoD Evolved Expendable Launch Vehicle (EELV) prime contractors, United Launch Alliance (ULA) and Space Exploration Technologies (SpaceX), and the ULA major subcontractor, Aerojet Rocketdyne (AR), performed adequate quality assurance management for the EELV program. Specifically, we evaluated EELV contractors’ compliance with the contractually required Aerospace Standard (AS) 9100C, “Quality Management Systems – Requirements for Aviation, Space, and Defense Organizations.”

Dec. 19, 2017

The Army Demilitarization Program DODIG-2018-052

We determined whether Army-held Operating Material and Supplies (OM&S) assets subject to demilitarization were properly reused and safeguarded or, when the assets were no longer required, were disposed of appropriately. We also determined whether the cost associated with storing and safeguarding the assets exceeded the cost of properly disposing of the assets.

Dec. 15, 2017

The Defense Finance and Accounting Service Financial Reporting Process for Other Defense Organizations’ General Funds DODIG-2018-041

We determined whether the Defense Finance and Accounting Service (DFAS) was properly accumulating and reporting Other Defense Organizations’ (ODOs’) General Fund financial data for the DoD Agency‐Wide financial statements. In addition, we followed up on the status of DFAS’s implementation of prior recommendations related to this audit objective.

Dec. 14, 2017

DoD’s Response to the Patient Safety Elements in the 2014 Military Health System Review DODIG-2018-036

We evaluated the DoD’s response to the August 2014 “Final Report to the Secretary of Defense, Military Health System [MHS] Review.”

Dec. 6, 2017

Glenn A. Fine, Principal Deputy Inspector General Performing the Duties of the Inspector General, testifies before the Senate Judiciary Committee on "Firearm Accessory Regulation and Enforcing Federal and State Reporting to the National Instant Criminal Background Check System"

Dec. 5, 2017

Evaluation of Fingerprint Card and Final Disposition Report Submissions by Military Service Law Enforcement Organizations DODIG-2018-035

The objective of our evaluation was to determine whether all Military Services Law Enforcement Organizations (LEOs) had submitted fingerprint cards and final disposition reports for Military Service members convicted by court-martial of qualifying offenses, as required by DoD instruction. We reviewed these submissions for the period from January 1, 2015, to December 31, 2016.

Dec. 1, 2017

Semiannual Report to the Congress: April 1, 2017 through September 30, 2017

This report summarizes the work of the Department of Defense (DoD) Office of Inspector General (OIG) from April 1, 2017, through September 30, 2017. It identifies oversight conducted by the OIG during the past 6 months, which demonstrates the importance of our efforts to detect and deter fraud, waste, and abuse in DoD programs and operations; to seek to improve the economy, efficiency, and effectiveness of DoD programs; and to help ensure ethical conduct throughout the DoD.

Nov. 20, 2017

Lead Inspector General for Operation Freedom's Sentinel | Quarterly Report to the United States Congress | July 1, 2017 – September 30, 2017

This Lead Inspector General (Lead IG) report to the United States Congress on Operation Freedom’s Sentinel is the 10th quarterly report detailing the overseas contingency operation (OCO). The report summarizes significant events involving OFS and describes completed, ongoing, and planned Lead IG and oversight partner agency work. This report covers the period from July 1, 2017, to September 30, 2017.

Nov. 20, 2017

Defense Health Agency Controls Over High-Risk Pharmaceutical Payments DODIG-2018-033

We determined whether the Defense Health Agency (DHA) developed controls to identify health care pharmaceutical payments at high risk of fraud or abuse. We focused on controls to prevent and detect potentially fraudulent or abusive claims for pharmaceuticals. The DHA defines “abuse” as any practice that is inconsistent with accepted practice which results in a claim, unnecessary costs, or payment for services or supplies not medically necessary and appropriate, or that fail to meet professionally recognized standards for health care providers. “ Abuse” includes deception or misrepresentation by a provider in relation to a TRICARE claim. We also reviewed the process for approving and implementing new controls.

Nov. 16, 2017

Implementation of the DoD Leahy Law Regarding Allegations of Child Sexual Abuse by Members of the Afghan National Defense and Security Forces DODIG-2018-018

To evaluate the implementation of the DoD Leahy Law regarding child sexual abuse as it applies to DoD interaction with, and Title 10 support of, the Afghan Security Ministries and the Afghan National Defense and Security Forces (ANDSF).